These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3464957)

  • 21. The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters.
    Pitman WA; Osgood DP; Smith D; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1998 May; 138(1):43-52. PubMed ID: 9678770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Ito T
    Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters.
    Bensch WR; Gadski RA; Bean JS; Beavers LS; Schmidt RJ; Perry DN; Murphy AT; McClure DB; Eacho PI; Breau AP; Archer RA; Kauffman RF
    J Pharmacol Exp Ther; 1999 Apr; 289(1):85-92. PubMed ID: 10086991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol.
    Ma PT; Yamamoto T; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1986 Feb; 83(3):792-6. PubMed ID: 2418443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of plasma cholesterol levels and induction of hepatic LDL receptor by cerivastatin sodium (CAS 143201-11-0, BAY w 6228), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, in dogs.
    Yasunobu Y; Hayashi K; Shingu T; Nomura K; Ohkura Y; Tanaka K; Kuga Y; Nomura S; Ohtani H; Nishimura T; Matsuura H; Kajiyama G
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):567-74. PubMed ID: 9358961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
    Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
    Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
    Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
    Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.
    Murakami S; Kondo Y; Toda Y; Kitajima H; Kameo K; Sakono M; Fukuda N
    Life Sci; 2002 Apr; 70(20):2355-66. PubMed ID: 12150200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle-specific requirement for mevalonate, but not for cholesterol, for DNA synthesis in glial primary cultures.
    Langan TJ; Volpe JJ
    J Neurochem; 1987 Aug; 49(2):513-21. PubMed ID: 3648095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines.
    Cerda SR; Wilkinson J; Broitman SA
    Lipids; 1995 Dec; 30(12):1083-92. PubMed ID: 8614298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits.
    Kuroda M; Matsumoto A; Itakura H; Watanabe Y; Ito T; Shiomi M; Fukushige J; Nara F; Fukami M; Tsujita Y
    Jpn J Pharmacol; 1992 May; 59(1):65-70. PubMed ID: 1507659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages.
    Traber MG; Kayden HJ
    Atherosclerosis; 1984 Jul; 52(1):1-11. PubMed ID: 6087838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.
    Grundy SM; Vega GL
    J Lipid Res; 1985 Dec; 26(12):1464-75. PubMed ID: 3853581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.